European Commission backs first ultra‑long‑acting biologic for respiratory disease

Move expands iPSC‑derived retinal model portfolio and strengthens position in research

Collaboration aims to speed access to challenging targets through an AI‑guided workflow

Bocunebart shows significant reduction in monthly migraine days in patients with previous treatment failures

New group aims to address structural barriers holding back Europe’s biotech scale‑up

FDA designation aims to speed development of new diagnostic tool

ProLectin‑M achieves 100% viral elimination by day seven in placebo‑controlled study

Biocodex secures rights to Batten-1 and TX01 in agreement worth up to €173 million

Regulator recommends durvalumab as first perioperative IO option for muscle‑invasive disease